21802721|relevance|C2347946|start=0|end=9|CONC
21802721|breast cancer|C0006142^C0678222|start=13|end=26|DISO
21802721|efficacy|C1280519^C1707887|start=70|end=78|PROC^CONC
21802721|adjuvant|C1522673|start=82|end=90|CONC
21802721|patient|C1578483^C1550655^C1578480^C1578481^C1578486^C1578484^C1578485^C1578479^C1578478|start=102|end=109|CONC^ANAT
21802721|level|C0456079^C1547707^C0441889|start=110|end=115|GEOG^CONC
21802721|analysis|C1524024^C0936012^C0002778|start=121|end=129|PROC^CONC
21802721|background|C1706907|start=152|end=162|CONC
21802721|years|C0439234|start=179|end=184|CONC
21802721|early|C1279919|start=201|end=206|CONC
21802721|breast cancer|C0006142^C0678222|start=207|end=220|DISO
21802721|mature|C0205286|start=221|end=227|CONC
21802721|relevance|C2347946|start=233|end=242|CONC
21802721|hormone receptor|C1367453|start=246|end=262|GENE
21802721|measurements|C0242485|start=263|end=275|CONC
21802721|patient characteristics|C0815172|start=287|end=310|PHYS
21802721|long-term|C0443252|start=315|end=324|CONC
21802721|outcome|C1274040|start=325|end=332|CONC
21802721|assessed|C1516048|start=340|end=348|ACTI
21802721|report|C0684224^C3273238^C0700287|start=375|end=381|PROC^CONC
21802721|years|C0439234|start=423|end=428|CONC
21802721|adjuvant|C1522673|start=432|end=440|CONC
21802721|methods|C0025664^C0449851^C0025663|start=452|end=459|CONC
21802721|collaborative|C0282116|start=476|end=489|ACTI
21802721|analysis|C1524024^C0936012^C0002778|start=495|end=503|PROC^CONC
21802721|individual|C3245468^C1550471|start=507|end=517|CONC
21802721|patient data|C2707520|start=518|end=530|CONC
21802721|early|C1279919|start=560|end=565|CONC
21802721|breast cancer|C0006142^C0678222|start=566|end=579|DISO
21802721|years|C0439234|start=591|end=596|CONC
21802721|adjuvant|C1522673|start=620|end=628|CONC
21802721|compliance|C3244300^C0009563^C1321605|start=655|end=665|ACTI^CONC
21802721|recurrence|C1458156^C0034897^C2825055|start=667|end=677|DISO^PHEN
21802721|death rate|C1108678^C0026565^C0205848|start=682|end=692|CONC
21802721|ratios|C0456603|start=693|end=699|CONC
21802721|rrs|C1849334|start=701|end=704|DISO
21802721|log|C2986775^C1708728|start=716|end=719|ACTI^CONC
21802721|rank|C0699794^C2827557^C1420805|start=720|end=724|GENE^CONC
21802721|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=747|end=756|PROC^CONC
21802721|findings|C2607943^C2926606^C3539655|start=758|end=766|PHYS^CONC
21802721|oestrogen receptor|C3811131|start=771|end=789|PROC
21802721|positive|C2825490^C1446409^C3812269|start=795|end=803|CONC
21802721|disease|C0012634|start=804|end=811|DISO
21802721|allocation|C1706778|start=824|end=834|ACTI
21802721|years|C0439234|start=846|end=851|CONC
21802721|reduced|C0392756|start=879|end=886|CONC
21802721|recurrence|C1458156^C0034897^C2825055|start=887|end=897|DISO^PHEN
21802721|years|C0439234|start=928|end=933|CONC
21802721|years|C0439234|start=960|end=965|CONC
21802721|years|C0439234|start=996|end=1001|CONC
21802721|years|C0439234|start=1051|end=1056|CONC
21802721|gain|C1517378|start=1086|end=1090|CONC
21802721|loss|C1517945|start=1094|end=1098|CONC
21802721|year|C1561543^C1561544^C0439234|start=1105|end=1109|CONC
21802721|disease|C0012634|start=1146|end=1153|DISO
21802721|fmol|C0439195|start=1161|end=1165|CONC
21802721|cytosol|C1383501|start=1169|end=1176|ANAT
21802721|protein|C0555903^C1521746|start=1177|end=1184|PROC^CONC
21802721|recurrence|C1458156^C0034897^C2825055|start=1190|end=1200|DISO^PHEN
21802721|reduction|C0301630^C0392756^C0441610|start=1201|end=1210|PROC^PHEN^CONC
21802721|disease|C0012634|start=1260|end=1267|DISO
21802721|approximately|C0332232|start=1280|end=1293|CONC
21802721|independent of|C0332291|start=1294|end=1308|CONC
21802721|progesterone receptor status|C1514471|start=1309|end=1337|PHYS
21802721|level|C0456079^C1547707^C0441889|start=1342|end=1347|GEOG^CONC
21802721|age|C1114365^C0001779|start=1350|end=1353|PHYS
21802721|nodal|C1417752^C0443268|start=1355|end=1360|GENE^CONC
21802721|status|C0449438^C1546481|start=1361|end=1367|CONC
21802721|use of|C1524063|start=1372|end=1378|CONC
21802721|chemotherapy|C0392920^C3665472^C0013217|start=1379|end=1391|PROC^CONC
21802721|breast cancer|C0006142^C0678222|start=1393|end=1406|DISO
21802721|mortality|C0026565^C0026566|start=1407|end=1416|CONC
21802721|reduced|C0392756|start=1421|end=1428|CONC
21802721|third|C0205437^C1705160|start=1440|end=1445|CONC
21802721|years|C0439234|start=1470|end=1475|CONC
21802721|years|C0439234|start=1499|end=1504|CONC
21802721|years|C0439234|start=1529|end=1534|CONC
21802721|years|C0439234|start=1563|end=1568|CONC
21802721|mortality|C0026565^C0026566|start=1595|end=1604|CONC
21802721|reduction|C0301630^C0392756^C0441610|start=1605|end=1614|PROC^PHEN^CONC
21802721|separate|C0443299|start=1627|end=1635|CONC
21802721|time period|C1948053^C0439582|start=1636|end=1647|CONC
21802721|non|C1518422|start=1658|end=1661|CONC
21802721|breast|C0006141^C1268990|start=1662|end=1668|ANAT
21802721|cancer mortality|C1516192|start=1669|end=1685|CONC
21802721|little|C0700321^C2700395|start=1690|end=1696|CONC
21802721|affected|C0392760|start=1697|end=1705|CONC
21802721|small|C0700321|start=1715|end=1720|CONC
21802721|absolute|C0205344|start=1721|end=1729|CONC
21802721|increases|C0442805^C0205217|start=1730|end=1739|CONC
21802721|thromboembolic|C0333214|start=1743|end=1757|CONC
21802721|uterine cancer|C3542435^C0153567|start=1762|end=1776|DISO^CONC
21802721|mortality|C0026565^C0026566|start=1777|end=1786|CONC
21802721|women|C1552469|start=1801|end=1806|OBJC^ORGA
21802721|years|C0439234|start=1821|end=1826|CONC
21802721|cause|C0015127^C1524003|start=1836|end=1841|CONC
21802721|mortality|C0026565^C0026566|start=1842|end=1851|CONC
21802721|reduced|C0392756|start=1870|end=1877|CONC
21802721|negative|C2825415^C0205160^C2825491|start=1885|end=1893|CONC
21802721|disease|C0012634|start=1894|end=1901|DISO
21802721|little|C0700321^C2700395|start=1917|end=1923|CONC
21802721|no effect|C1301751|start=1927|end=1936|CONC
21802721|breast cancer|C0006142^C0678222|start=1940|end=1953|DISO
21802721|recurrence|C1458156^C0034897^C2825055|start=1954|end=1964|DISO^PHEN
21802721|mortality|C0026565^C0026566|start=1968|end=1977|CONC
21802721|interpretation|C0459471^C3173575|start=1979|end=1993|PHYS^CONC
21802721|years|C0439234|start=1997|end=2002|CONC
21802721|adjuvant|C1522673|start=2006|end=2014|CONC
21802721|risks|C0035647|start=2048|end=2053|CONC
21802721|breast cancer|C0006142^C0678222|start=2057|end=2070|DISO
21802721|recurrence|C1458156^C0034897^C2825055|start=2071|end=2081|DISO^PHEN
21802721|death|C1546949^C0011065|start=2086|end=2091|PHYS^CONC
21802721|er status|C1516974|start=2093|end=2102|PHYS
21802721|factor|C1521761^C2827422|start=2125|end=2131|CONC
21802721|predictive|C0681890|start=2144|end=2154|CONC
21802721|proportional|C0205351|start=2162|end=2174|CONC
21802721|reductions|C0301630^C0441610|start=2175|end=2185|PROC^PHEN
21802721|absolute risk reductions|C3179139|start=2198|end=2222|CONC
21802721|depend|C0725813|start=2245|end=2251|DEVI
21802721|absolute|C0205344|start=2259|end=2267|CONC
21802721|breast cancer|C0006142^C0678222|start=2268|end=2281|DISO
21802721|risks|C0035647|start=2282|end=2287|CONC
21802721|chemotherapy|C0392920^C3665472^C0013217|start=2299|end=2311|PROC^CONC
21802721|funding|C0243098^C0376244|start=2332|end=2339|CONC
21802721|cancer research|C1516225|start=2341|end=2356|PROC
21802721|heart|C0018787^C1281570|start=2369|end=2374|ANAT
21802721|foundation|C0016617|start=2375|end=2385|ORGA
21802721|medical research|C0079816|start=2391|end=2407|PROC
